MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

MEI Pharma Company Profile (NASDAQ:MEIP)

Consensus Ratings for MEI Pharma (NASDAQ:MEIP) (?)
Ratings Breakdown: 1 Hold Rating(s), 2 Buy Rating(s)
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $2.00 (40.85% upside)

Analysts' Ratings History for MEI Pharma (NASDAQ:MEIP)
Show:
DateFirmActionRatingPrice TargetActions
4/18/2016WedbushLower Price TargetNeutral$3.00 -> $2.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/7/2015Cowen and CompanyReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/2/2015Cantor FitzgeraldReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/24/2015Bank of AmericaDowngradeBuy -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/24/2015Wells FargoDowngradeOutperform -> Market Perform$2.25 -> $2.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/23/2015Stifel NicolausDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/23/2015Roth CapitalDowngradeBuy -> Neutral$14.00 -> $2.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/8/2014Brean CapitalInitiated CoverageBuy$16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/4/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha